Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.34 |
| ▸ | FABP3 | P05413 | 2/20 | 0.33 |
| ▸ | FABP4 | P15090 | 2/20 | 0.33 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.30 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL338867 | 0.78 | GABRA1 (0.46) | GABRA1GABRB2FABP3FABP4FABP5 | |
| SCHEMBL1479773 | 0.76 | FABP3 (0.37) | GABRA1GABRB2FABP3FABP4FABP5 | |
| Calcium SCHEMBL29750665 | 0.75 | GABRA1 (0.43) | GABRA1GABRB2FABP3FABP4FABP5 | |
| SCHEMBL29415630 | 0.75 | GABRA1 (0.43) | GABRA1GABRB2FABP3FABP4FABP5 | |
| SCHEMBL28414081 | 0.75 | GABRA1 (0.43) | GABRA1GABRB2FABP3FABP4FABP5 | |
| SCHEMBL23202783 | 0.75 | GABRA1 (0.43) | GABRA1GABRB2FABP3FABP4FABP5 | |
| Hydrochloric Acid SCHEMBL5790729 | 0.75 | GABRA1 (0.43) | GABRA1GABRB2FABP3FABP4FABP5 | |
| SCHEMBL23202734 | 0.75 | GABRA1 (0.43) | GABRA1GABRB2FABP3FABP4FABP5 | |
| SCHEMBL3234036 | 0.75 | GABRA1 (0.43) | GABRA1GABRB2FABP3FABP4FABP5 | |
| Hydrogen Sulfide SCHEMBL28283354 | 0.75 | GABRA1 (0.43) | GABRA1GABRB2FABP3FABP4FABP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10392451-B2 | Ligand compound, organic chromium compound, catalyst system for olefin oligomerization, and method for oligomerizing olefins using the same thereof | LG CHEM, LTD. (KR) | 2019-08-27 | — | — | US | disclosed |
| US-20180086860-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, CATALYST SYSTEM FOR OLEFIN OLIGOMERIZATION, AND METHOD FOR OLIGOMERIZING OLEFINS USING THE SAME | LG CHEM, LTD. (KR) | 2018-03-29 | — | — | US | disclosed |
| US-20180086860-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, CATALYST SYSTEM FOR OLEFIN OLIGOMERIZATION, AND METHOD FOR OLIGOMERIZING OLEFINS USING THE SAME | LG CHEM, LTD. (KR) | 2018-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180086860-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, CATALYST SYSTEM FOR OLEFIN OLIGOMERIZATION, AND METHOD FOR OLIGOMERIZING OLEFINS USING THE SAME | OXER1, OSTC, ORC3 | GABRA1 2334/4885GABRB2 2803/4885FABP3 4134/4885 |
| US-10392451-B2 | Ligand compound, organic chromium compound, catalyst system for olefin oligomerization, and method for oligomerizing olefins using the same thereof | OXER1, OSTC, ORC3 | GABRA1 2248/4885GABRB2 2744/4885FABP3 4138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.